Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to ResearchAndMarkets.com's offering. The global market for IV therapy and ...

Clinical question: In patients presenting to the intensive care unit (ICU) for sepsis, which intravenous (IV) fluid resuscitation strategy (restrictive, liberal, or moderate) is optimal for lower ...

What is Vitamin IV therapy? Vitamin IV (Intravenous) therapy involves delivering vitamins and minerals directly into the bloodstream via an IV drip.

Enhancing Energy Levels and Recovery IV therapy stands out as an impactful means to bolster energy and vitality, particularly among individuals with demanding lifestyles. The intravenous route ...

Trials that compared sodium bicarbonate and sodium chloride for the prevention of contrast-induced acute kidney injury have yielded highly conflicting results. The authors of a recent meta ...

But IV nutrition therapy has also become popular among the wellness crowd in recent years, thanks to potential perks such as fighting fatigue, boosting immunity, and easing stress. IV nutrition ...

CMS is extending the 2024 merit-based incentive payment system deadline and reopening the extreme and uncontrollable circumstances exception for disruptions related to the intravenous fluid shortage.

What if you could save 98 percent of CO₂ emissions during surgery with just one change? And what if that change also improved patient recovery and saved costs? Then you's probably want to ...

The clinical determination of the intravascular volume can be extremely difficult in critically ill and injured patients as well as those undergoing major surgery. This is problematic as fluid ...

The American Medical Association is urging CMS to reopen a payment program exception before a March 31 deadline as a nationwide intravenous fluid shortage pummels the healthcare industry.

Now these bits of plastic -- from 1 to 62 micrometers long -- have been found in the filtered solutions used for medical intravenous (IV) infusions.

A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the ...